Sleep and stroke by SALIM DIB et al.
Sleep and stroke
Abstract
Obstructive Sleep-Disordered Breathing (OSDB) is an under-recognized
risk factor for stroke. OSDB is associated with traditional vascular risk factors
such as hypertension, obesity, and diabetes, and can influence the risk for
stroke through direct and indirect mechanisms. Untreated OSDB may also
influence rehabilitation efforts and functional outcome following a stroke, as
well as the risk for stroke recurrence. Stroke risk is greatly reduced if the
OSDB is adequately treated. Conversely, OSDB may be exacerbated or
caused by stroke. Increasing awareness and improving screening for OSDB is
paramount in the primary and secondary prevention of stroke, and in improv-
ing stroke outcomes.
The following review article is intended to highlight the current basics of
epidemiology, clinical characteristics, pathophysiology, diagnosis, and treat-
ment of OSDB in relation to stroke.
INTRODUCTION
Obstructive Sleep-Disordered Breathing (OSDB) describes a group
of disorders characterized by abnormalities of respiratory pattern or
ventilation during sleep related to upper airway obstruction. OSDB
includes habitual snoring, upper airway resistance syndrome (UARS), and
obstructive sleep apnea (OSA), which is characterized by repetitive parti-
al or complete collapse of the pharyngeal airway during sleep leading to
oxygen desaturation and the need to arouse to resume ventilation (1, 2).
Sleep is thus disrupted, yielding waking somnolence and diminished
neurocognitive performance which may impede stroke rehabilitation,
lengthen hospital stay, and influence stroke outcomes and risk of recur-
rence (3, 4). The recurrent sleep arousal in association with intermit-
tent hypoxia and hypercapnia has been implicated in the occurrence of
adverse cardiovascular outcomes. In addition, there is evolving evidence
that OSDB may contribute to insulin resistance and other components
of the metabolic syndrome.
Epidemiology
It is estimated that over 90 million Americans, or up to 40% of the
adult U.S. population, suffer from loud habitual snoring.5–7 In the UK,
an estimated 41.5% of the adult population snore, or 14.9 million
adults, with a male to female ratio of approximately 2:1 (8).
Obstructive sleep apnea (OSA) affects up to 17% of the adult popu-
lation, and up to 25% of patients over 65 years of age (9–11). The
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Overview
including hypertension, coronary artery disease, stroke,
and congestive heart failure (CHF) (12).
There are ethnic differences in the prevalence of snor-
ing and OSA with higher prevalence reported in His-
panics and African Americans (13–15).
Despite considerable progress, most patients with
OSDB remain undiagnosed. It has been suggested that
93% of women and 82% of men with signs and symp-
toms of moderate to severe OSDB remain untreated (10).
Clinical characteristics
Symptoms of OSA include snoring, gasping or chock-
ing during sleep, restless sleep, and excessive daytime
sleepiness. It can also result in impaired cognition, irrita-
bility, and mood changes. Daytime sleepiness is one of
the cardinal symptoms of OSA. Multiple models have
been developed to assess the degree of daytime sleepi-
ness. The Epworth sleepiness scale (ESS) is commonly
used (16). It rates self-reports of dozing off uninten-
tionally during the day in sedentary situations (Table 2).
Risk factors for OSBD include obesity, male gender,
increased neck circumference (³ 17 inches in men; ³ 16
inches in women), cranio-facial features (e.g. retrogna-
thia and micrognathia), nasal obstruction, large tonsils
(especially in children), ethnic background, and hypo-
thyroidism (2, 10). The use of alcohol, tobacco, and
sedatives further increases the risk.
Risk predictive models have also been proposed to
identify individuals at high risk for obstructive sleep
apnea. One of the most commonly used is the Berlin
questionnaire, which combines risk factors such as snor-
ing, daytime sleepiness, obesity, and hypertension to reli-
ably predict OSA from polysomnography (PSG) (17);
(Table 3, Table 4).
Sleep, blood pressure, and risk of
stroke
Stroke shares an identical double-peak 24 h pattern
with many acute cardiovascular events with a major
morning peak and secondary early evening peak, which
parallels the circadian variation in blood pressure (18, 19).
Blood pressure exhibits a prominent 24 hour rhythm,
with two daytime peaks, the first around 9 a.m. and the
second around 7 p.m, and a nadir during sleep (20).
Excessive morning BP surge has been associated with a
2.7 fold increase risk of stroke in the elderly (21).
Normally, BP decreases by 10–20% during NREM
sleep as compared to daytime levels (20). A variety of
abnormal BP variation patterns have been described in
which the nocturnal fall of BP may be > 20% (extreme-
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TABLE 1
Sleep terms and definitions.
Term Definition
Apnea Cessation of airflow for at least 10 s, usually accompanied by oxygen desaturation
Hypopnea Reduction in airflow by at least 30–50% of baseline, usually accompanied by oxygen desaturation
or an arousal
Arousal Awakening from sleep lasting 3 to 15 s
Apnea- hypopnea index (AHI) Number of apneas and hypopneas per hour of sleep, a marker of sleep apnea severity
Sleep apnea syndrome At least 5 apneas and hypopneas per hour of sleep, associated with complaints of snoring,
breathing pauses, insomnia, unrefreshing sleep, excessive daytime sleepiness or fatigue
TABLE 2
Epworth Sleepiness Scale




Sitting inactive in a public place [theater/meeting]
As a passenger in a car for an hour without a break
Lying down to rest in the afternoon when circumstances permit
Sitting quietly after a lunch without alcohol
Sitting and talking to someone
In a car, while stopped for a few minutes in traffic
0= no chance of dozing
1= slight chance of dozing
2= moderate chance of dozing
3= high chance of dozing
ESS score is ³ 10 is consistent with Excessive Daytime Sleepiness.
TABLE 3
Berlin Questionnaire
Sleep apnea risk stratification.
Check if present
Loud Habitual Snoring (at least
3 times per week)
Daytime Sleepiness (ESS ³ 10)
(at least 3 times per week)
Hypertension
Obesity (BMI >30 kg/m2)
Presence of two out of the four above factors predicts OSA with a
sensitivity of 86%, specificity of 77%, and positive predictive value of
89%.
-dippers), < 10% (non-dippers), or < 0% (reversed-
-dippers, with nocturnal BP exceeding daytime BP) (22).
Prospective studies have shown that patients who do not
experience typical BP »dipping« during sleep are at in-
creased risk for end organ damage, including left ventri-
cular hypertrophy, myocardial infarction, congestive heart
failure, vascular dementia and stroke (20, 22, 23). Ex-
treme-dipper, non-dipper or reverse-dipper pattern have
all been associated with intracranial hemorrhages, ische-
mic strokes, silent brain infarcts, and stroke deaths (24–26).
The Ohasama study, a population-based study of the
prognostic value of ambulatory BP monitoring in over
1,500 Japanese subjects, found that after an average
follow up of 9.2 years, a 5% decrease in the nocturnal
systolic BP in hypertensive patients was associated with
approximately a 20% increased risk of cardiovascular
mortality (26). In addition, 'dipper hypertensives' had a
risk of cardiovascular mortality (HR 2.4; 95% CI:
1.5–3.8) similar to that of 'non-dipper hypertensives'
(HR 2.2; 95% CI: 1.3–3.6). These results suggest that loss
of nocturnal BP dipping is a significant risk factor of
cardiovascular mortality, independent of 24–hour mean
BP. Hence, altered diurnal BP pattern with absence of
nocturnal BP dipping represents an important risk factor
for stroke and cardiovascular events.
Obstructive Sleep-Disordered Breathing
and Stroke
Habitual snoring is considered an independent risk
factor for stroke, with a risk estimate of 1.7, similar to that
of traditional risk factors (27, 28). It is more strongly
associated with stroke during sleep (29). It has also been
associated with carotid atherosclerosis, and was found to
have an adverse effect on stroke outcome (30).
There seems to be a dose-response relationship be-
tween OSA and cardiovascular disease including stroke
(31). The association between OSA and stroke has been
established in multiple observational cohort studies (Tab-
le 5) (27, 28, 32, 33). In a cross-sectional analysis of 6,000
subjects from Sleep Heart Health Study, stroke prevalent
(OR: 1.6; 95 % CI 1.02–2.5) was greater among subjects
with OSA (31). A cross-sectional analysis from the Wis-
consin Sleep Cohort study of 1,475 individuals showed
an increased risk of stroke in subjects with an AHI=20
(OR 3.8; 95% CI: 1.2–12.6) after controlling for covaria-
tes (32). In another observational cohort study of patients
referred to an academic sleep center for the evaluation of
sleep disordered breathing, OSA was associated with an
increased risk of stroke or death (HR, hazard ratio 3.3;
95% CI: 1.7–6.3) independently of demographics and
vascular risk factors. In the recent prospective analyses
from the Sleep Heart Health Study with a median follow
up of 8.7 years. OSA at all levels of severity was associated
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TABLE 4
Population at high risk for sleep disordered breathing.




prompting sleep evaluation by
PSG
History of Stroke Daytime sleepiness (³ 10 ESS)*
Obesity (BMI > 30)* Loud and habitual snoring*
Congestive heart failure History of hypertension*
Atrial fibrillation Gasping/choking at night
Refractory hypertension Witnessed apneas
Type 2 diabetes Morning headaches
Nocturnal dysrhythmias Frequent awakenings
Non- dipping BP Memory loss
Pulmonary hypertension Decreased concentration
Shift workers Frequent nocturia
* Berlin Questionnaire items.
ESS: Epworth Sleepiness Scale; BMI: body mass index; BP:
blood pressure.
TABLE 5
Sleep disorders, cardiovascular disease and stroke in epidemiological studies.
STUDY DESIGN N OUTCOME OR/HR (95% CI)
OSA
SHHS
Shahar et al., 2001







Arzt et al., 2005
Cross- sectional 1,475 Stroke 3.8 (1.2–12.5)
Yaggi et al., 2005 Prospective cohort 1,022 Stroke or death 2.0 (1.1–3.5)
Munoz et al., 2006 Prospective cohort 394 Stroke 2.5 (1.0–6.0)
SHHS
Redline et al., 2010
Prospective cohort 5,422 Stroke Men, 2.9 (1.1–7.4)
Women, 1.2 (0.7–2.2)
OR, odds ratio; HR, hazards ratio; OSA, obstructive sleep apnea; SHHS, Sleep Heart Health Study; PSG, polysomnography; HTN, hypertension;
CVD, cardiovascular disease; CAD, coronary artery disease; WSC, Wisconsin Sleep Cohort; ARIC, Atherosclerosis Risk In Communities
with an increased risk of stroke in men (for the top AHI
quartile of >19, an adjusted HR 2.9; 95% CI: 1.1–7.4)
but not in women (33). There was an increased risk of
stroke in women only with an AHI of more than 25 (33).
A recent meta-analysis of 29 studies has reported that up
to 72% of stroke patients have OSA, as defined by an AHI
greater than 5 (34). The patients with »cryptogenic
stroke« had the highest incidence of OSA, raising the
possibility that OSA may be an important cause of
ischemic stroke of undetermined etiology (34).
Mechanisms leading to stroke
Several direct and indirect mechanisms have been
proposed to explain the increased risk of stroke in patients
with OSDB. These include the effects of hypoxemia, sym-
pathetic surges, nocturnal hypertension, reduction in ce-
rebral blood flow, altered cerebral autoregulation, impair-
ed endothelial function, increased platelet activation,
metabolic dysregulation (increased leptin levels and im-
paired glucose tolerance), increased inflammation, in-
creased oxidative stress related to intermittent hypoxia,
cardiac arrhythmias, and cardioembolism (35–37).
Damage to endothelial cells may occur by oxidative
stress during hypoxemia related to apneas, and shear
stress onto blood vessel walls from large fluctuations in
blood pressure during the obstructive events and sus-
tained hypertension (36, 37). Arousals from sleep as-
sociated to increased sympathetic surges, may play a
significant role in the amount of »non-dipping« of BP in
sleep leading to nocturnalhypertension (35). Obstructive
events can lead to reductions in cerebral blood flow (CBF)
and impaired cerebral autoregulation (38). Changes in
intrathoracic pressures during obstructive events may
reduce CBF increasing the risk of stroke in vulnerable
patients (39). Also, decrease CBF and impaired vaso-
motor reactivity have been observed during wakefulness
in subjects with OSA (38). These mechanisms may cause
cerebral small vessel disease as well as cerebral white
matter disease, and lead to subclinical cerebrovascular
damage and permanent structural changes to the brain.
Another important mechanism which may cause cli-
nical deterioration during an acute ischemic stroke is the
Reversed Robin Hood Syndrome (RRHS). This is an
intracranial steal phenomenon associated with neuro-
logical deterioration in up to 7% of acute stroke patients.
Oxygen desaturations coupled with hypercapnia during
obstructions in OSA can trigger this cerebral blood steal
phenomenon (39).
Obstructive Sleep Apnea and Stroke
Risk Factors
The association between OSA and vascular disease
may be in part mediated by the presence of major vascular
risk factors including hypertension, diabetes, and obesity.
OSA is an independent risk factor for systemic hy-
pertension, and increases the risk of hypertension in a
dose-response pattern (40). An AHI greater than 5 and
less than 15 is associated with a 2 fold increased risk of
developing hypertension at 4 year follow up, and an
AHI> 15 is associated with a 3 fold increased risk (32,
41). A high prevalence of OSA is also described in treat-
ment resistant hypertension (42).
Obstructive sleep apnea is linked to type 2 diabetes by
its effect on insulin resistance and cortisol levels (43).
OSA is also associated with altered levels of leptin, a
hormone secreted by adipocytes, which promotes the
sensation of satiety and increases the metabolic rate (44).
Untreated OSA causes resistance to the metabolic effects
of leptin, promoting weight gain and obesity in this po-
pulation.
OSA and Cardioembolic Risk
OSA has also been linked to cardioembolic risk factors
including patent foramen ovale (PFO) and cardiac ar-
rhythmias. An increased risk of cardioembolism through
paradoxical emboli has been suggested in patients with
OSA (45). This may occur through increased intrathora-
cic pressure during apneas (46).
Heart rate variability is seen with sleep apneas and hy-
popneas with slowing of the heart rate during the event,
followed by an increased rate or tachycardia with the
initial restorative breath or hyperpnea phase, often
associated with an arousal from sleep. This has been
described as »brady-tachy« pattern and is the most com-
mon form of arrhythmia with OSA. Multiple arrhythmias
have been documented in patients with OSA including
sinus pauses, bradycardia, supraventricular tachycardia,
ventricular tachycardia, second or third degree heart block,
and atrial fibrillation. The majority of the arrhythmias
are seen in stages N1, N2 and REM sleep.
An AHI greater or equal to 30 is associated with a 4
fold increased risk of Atrial Fibrillation, a 3.4 fold in-
creased risk of non-sustained ventricular tachycardia,
and 1. 74 fold increased risk of complex ventricular ec-
topy (47).
Up to 40% of symptomatic Atrial Fibrillation (AF)
episodes occur between midnight and 8 a.m. (48). Ob-
servational studies have shown an improvement or re-
solution of cardiac arrhythmias and atrial fibrillation
with OSA treatment (49).
OSA and subclinical vascular disease
The effect of OSA on subclinical vascular disease has
been reported. In a cross-sectional study of Japanese
men, brain magnetic resonance imaging revealed silent
brain infarcts in 25% of patients with moderate to severe
OSA but in only 8% of patients with mild OSA, and in
6% of control subjects, suggesting that OSA may elicit
early and asymptomatic cerebrovascular damage (50).
Subclinical carotid atherosclerosis (carotid intima-media
thickness, IMT) has been proposed as an intermediary
between OSA and stroke, but this relationship remains
controversial. In the two large population based studies,
Northern Manhattan Study and SHHS, snoring and in-
somnia were not associated with increased levels of carot-
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id IMT (51, 52). However, another study reported a
significant association between severe OSA and carotid
atherosclerosis (53). This study however, involved a rela-
tively small number of subjects referred to a tertiary care
center.
Sleep Disorders and Stroke
Rehabilitation and Outcomes
Although data is limited, poor sleep quality or duration
may significantly impair inpatient stroke rehabilitation
efforts. Sleep disorders impede the restorative processes,
which occur during undisturbed sleep (54). Obstructive
sleep apnea is associated with depressive symptoms, day-
time sleepiness, fatigue, and executive dysfunction, all of
which can limit a patient’s rehabilitation regimen (1, 4,
50). Stroke patients with untreated sleep disorders may
also lack the motivation, energy, and concentration ne-
cessary to participate in intensive rehabilitation therapy.
In a recent small randomized trial in 22 patients with
OSA, CPAP treatment after stroke has been shown to im-
prove motor functional recovery and depressive symp-
toms, but not cognitive impairment (55). Thus, treatment
of sleep disorders in patients with stroke may help maxi-
mize stroke recovery.
Diagnosis and Treatment of obstructive
sleep-disordered breathing
Polyomnography (PSG) is the gold standard for the
diagnosis of OSDB. A standard montage includes elec-
troencephalography (EEG), electrooculography (EOG),
electromyography (EMG), electrocardiography (EKG),
and respiratory activity with audiovisual correlation to
detect sleeping disturbances.
Continuous positive airway pressure (CPAP) is the
first-line treatment for patients with moderate to severe
OSA. CPAP is administrated by a small motorized unit
that pushes pressurized air through a hose attached to a
mask strapped on the patient’s face. CPAP works as a
»pneumatic splint« by delivering a positive intraluminal
pressure, alleviating the repetitive episodes of upper air-
way collapse characteristic of sleep apnea, and completely
or partially reversing its daytime consequences. Aside
from improving sleep quality and daytime symptoms
related to OSA, CPAP has been shown to decrease risk
for cardiovascular events and has modest effects on BP
(56, 57). Its benefits are directly related to its adherence
with improvements in subjective sleepiness achieved with
> 4 hours of nightly, use while mild decreases in BP
(1.89 mm Hg in systolic BP and 2.19 mm Hg in diastolic
BP) require a minimum of 5.6 hours of nightly use (57).
The benefits and timing of CPAP therapy during an
acute stroke however have not been established. The
effects of CPAP therapy on BP during an acute stroke are
not well known. CPAP treatment therefore may be pro-
blematic in acute stroke patients that are vulnerable to
changes in cerebral blood flow. In addition, the severity
and type of sleep apnea may evolve from the acute to the
chronic stroke phase (4). Acute stroke patients may show
poor CPAP adherence due to cognitive and motor im-
pairment that hinders appropriate mask fit and
placement. An alternative option for inpatient treatment
for OSA may be positional therapy (avoiding supine
positioning), which has showed modest decreases in the
AHI of about 20% compared to sleeping at lib (58). A
5-year prospective observational study of patients with
OSA two months after stroke showed that those with
moderate or severe OSA who were non-adherent to
CPAP had increased mortality (HR 1.6; 95% CI: 1.0–2.5)
from cardiovascular disease or stroke as compared to
CPAP adherent patients (59). Randomized clinical trials
studying the effects of CPAP therapy on stroke outcomes
and recurrence are currently on-going; however, given its
high benefit to risk ratio, stroke patients with OSA should
be encouraged to use CPAP regularly as part of standard
stroke care. Larger studies are needed to determine the
optimal timing of CPAP therapy after stroke, determinants
of CPAP adherence in stroke patients, and the effects of
CPAP use on stroke risk reduction and mortality.
FUTURE DIRECTIONS
Data is limited regarding the impact of sleep-dis-
ordered breathing and its treatment on incidence and
recurrence of stroke, and regarding race-ethnic preva-
lence of sleep disorders. This may be of importance in
stroke prevention, as Hispanics have a 2-fold increased
risk for stroke in comparison to whites (60). A large
multicenter epidemiological study, the Hispanics Com-
munity Health Study, will evaluate the effect of sleep
disorders on adverse cardiovascular outcomes in the US
Hispanic population (61). Several trials are currently
investigating the effects of OSA treatment with CPAP on
future cardiovascular events, including a large on-going
trial in Australia (Sleep Apnea CardioVascular Endpoints
Study, a China-Australia collaborative multi-centre trial).
Studies are also needed to determine the effect of treat-
ment of post-stroke sleep-disordered breathing on reha-
bilitation efforts and stroke outcomes. Increasing public
awareness and improving healthcare professional educa-
tion about the effects of sleep disorders, as well as screen-
ing methods, management, and prevention is an impor-
tant first step given the emerging evidence that sleep-
-disordered breathing is a modifiable stroke risk factor.
Finally, educating stroke patients and their caregivers
regarding the impact of sleep-disordered breathing on
stroke recovery and risk of stroke recurrence would help
improve compliance with treatment.
CONCLUSION
Sleep-disordered breathing is prevalent in the general
population, especially in those with vascular risk factors,
and in stroke victims. Screening for sleep disorders should
become a standard part of stroke prevention, evaluation,
and management. Collaboration between stroke and sleep
specialists would further improve our understanding of
the relationship between sleep-disordered breathing and
stroke, may ensure early implementation of screening
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and preventive strategies, and subsequently improve cli-
nical outcomes for stroke patients. Finally, more innova-
tive and effective strategies in educating health care pro-
fessionals and the public about sleep disorders and their
effect on stroke and cardiovascular disease are funda-
mental.
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